Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
Clinical trial NCT04033159 · TERMINATED
Trial details
- NCT number
- NCT04033159
- Sponsor
- Dynacure
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2022-06-22
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.